Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19.12.24Novo completes $16.5bn takeover of Catalent
19.12.24Ottimo raises $140m for its PD-1/VEGF cancer drug
19.12.24MSD makes its obesity move with $2bn Hansoh deal
19.12.24Mesoblast finally pushes GvHD cell therapy over finish line
18.12.24Novo Holdings leads $100m round for novel painkiller biotech
18.12.24Sensorion encouraged by deafness gene therapy data
18.12.24Lilly's Alzheimer's drug Kisunla is cleared in China
18.12.24MSD eyes June verdict for paediatric RSV antibody
18.12.24UnitedHealth killing suspect gets first-degree murder charge
17.12.24Teva, Sanofi score well with anti-TL1A drug in IBD test
17.12.24Study backs Closed Loop's drug+digital blood pressure plan
17.12.24End of the line for MSD's TIGIT, LAG-3 cancer drugs
17.12.24FDA dents J&J's blockbuster hopes for Rybrevant
17.12.24PBM reform looms in end-of-year US legislation package
16.12.24FDA clears Neurocrine drug for rare adrenal disorder
16.12.24Novo sets aside $1.2bn for rare diseases plant
16.12.24Galderma adds new indication for blockbuster hope Nemluvio
16.12.24New drugs 'benefit patients, but maybe not populations'
16.12.24AbbVie adds psoriasis med with Nimble takeover
13.12.24ICER identifies new crop of 'unsupported' drug price rises
13.12.24Top podcaster spread health misinformation, claims BBC probe
13.12.24Editas axes two-thirds of its staff, including its CMO
13.12.24Safety fear halts Keros PAH trial dosing, hitting its shares
13.12.24Carlyle backs Essential refinancing and other funding news
12.12.24NIH abandons trial of SIGA's mpox drug